Bifidobacterium longum peptide-1
Bifidobacterium longum peptide-1 has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 12, 2023: “Ameliorative effects of Bifidobacterium longum peptide-1 on benzo(α)pyrene induced oxidative damages via daf-16 in Caenorhabditis elegans”.
1 paper studies it3 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Cheng Kung University
- Model organisms1
What did studies of Bifidobacterium longum peptide-1 find?
3Studies of Bifidobacterium longum peptide-1 measured 3 outcomes; the most studied are oxidative stress and ROS signaling (1 study), motility (1) and lifespan (1).
Oxidative stress and ROS signaling
downin worms1
1 study
Oxidative stress and ROS signaling
downin worms1
Bifidobacterium longum peptide-1 decreases oxidative stress and ROS signaling in worms.
“Interestingly, when further treated with B. longum peptide-1 (BLP-1), opposite effects were observed, and all the aforementioned indices changed significantly.”
Model organismsin BaP-exposed worms
Cell stress & chaperones
Motility
upin worms1
1 study
Motility
upin worms1
Bifidobacterium longum peptide-1 improves motility in worms.
“Interestingly, when further treated with B. longum peptide-1 (BLP-1), opposite effects were observed, and all the aforementioned indices changed significantly.”
Model organismsin BaP-exposed worms
Cell stress & chaperones
Lifespan
upin worms1
1 study
Lifespan
upin worms1
Bifidobacterium longum peptide-1 extends lifespan in worms.
“Interestingly, when further treated with B. longum peptide-1 (BLP-1), opposite effects were observed, and all the aforementioned indices changed significantly.”
Model organismsin BaP-exposed worms
Cell stress & chaperones